Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Single-stranded DNA adenine bases within the ABE7.10 editing window are the specific molecular targets for Adenine Base Editors (ABEs), which are engineered tools designed for precise genome editing. ABE7.10 is a prominent variant composed of a nickase Cas9 (nCas9) fused to an evolved TadA deoxyadenosine deaminase domain (Gaudelli et al., Nature, 2017). When the CRISPR-Cas9 system targets a specific genomic sequence, it unwinds the DNA double helix, creating a single-stranded DNA loop known as an R-loop. Within a specific "window" of this loop—typically positions 4 through 7 or 8 of the protospacer—the adenine bases become accessible to the deaminase enzyme (Rees & Liu, Nature Reviews Genetics, 2018). The enzyme catalyzes the conversion of adenine to inosine, which the cell's machinery subsequently recognizes as guanine during DNA replication or repair, resulting in a permanent A•T to G•C base pair transition (Kantor et al., Chemical Reviews, 2020). This mechanism allows for the correction of pathogenic point mutations responsible for numerous genetic diseases without the need for double-strand breaks or donor DNA templates. However, the presence of multiple adenines within the window can lead to bystander editing, which remains a significant consideration in therapeutic design.
Hydrolytic deamination of adenine to inosine within the single-stranded DNA bubble created by a CRISPR-Cas9 complex, followed by DNA replication or repair that treats inosine as guanine, resulting in an A-to-G transition.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenine bases in single-stranded DNA (ABE7.10 editing window) (ssDNA Adenine (ABE7.10)).